ATRECA INC's ticker is BCEL and the CUSIP is 04965G109. A total of 47 filers reported holding ATRECA INC in Q4 2019. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $967,000 | -44.4% | 113,455 | 0.0% | 0.24% | -32.0% |
| Q1 2021 | $1,739,000 | -16.2% | 113,455 | -11.7% | 0.35% | -16.9% |
| Q4 2020 | $2,075,000 | +88.6% | 128,455 | +63.1% | 0.42% | +95.0% |
| Q3 2020 | $1,100,000 | +140.2% | 78,768 | +266.0% | 0.22% | +62.7% |
| Q2 2020 | $458,000 | -41.4% | 21,523 | -54.5% | 0.13% | -48.9% |
| Q1 2020 | $782,000 | -40.8% | 47,252 | -44.6% | 0.26% | -16.6% |
| Q4 2019 | $1,320,000 | – | 85,312 | – | 0.31% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Copernicus Capital Management, LLC | 18,000 | $276,000 | 4.46% |
| Bill & Melinda Gates Foundation | 1,396,644 | $21,411,000 | 3.50% |
| EcoR1 Capital, LLC | 2,426,685 | $37,201,000 | 1.65% |
| Boxer Capital, LLC | 2,202,333 | $33,762,000 | 1.14% |
| Samsara BioCapital, LLC | 396,835 | $6,083,000 | 1.12% |
| Aisling Capital Management LP | 387,653 | $5,943,000 | 1.07% |
| CM Management, LLC | 60,000 | $920,000 | 0.68% |
| Parkman Healthcare Partners LLC | 151,993 | $2,330,000 | 0.54% |
| Redmile Group, LLC | 2,490,568 | $38,180,000 | 0.54% |
| HighVista Strategies LLC | 34,301 | $526,000 | 0.39% |